[VRDN] QoQ Quarter Result on 31-Mar-2016 [#Q1]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
16-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- 7.45%
YoY- -4.71%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Revenue 756 889 874 818 659 501 734 1.97%
PBT -5,570 -1,839 -2,507 -2,758 -2,980 -3,152 -2,562 67.42%
Tax -71 0 0 0 -47 0 0 -
NP -5,570 -1,839 -2,507 -2,758 -2,980 -3,152 -2,562 67.42%
Tax Rate - - - - - - - -
Total Cost 6,326 2,728 3,381 3,576 3,639 3,653 3,296 54.13%
Ratio Analysis
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
NP Margin -736.77 -206.86 -286.84 -337.16 -452.20 -629.14 -349.05 64.17%
Per Share
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
EPS -7.23 -2.56 -3.50 -3.85 -4.19 -5.82 -4.94 28.75%
EPS Diluted -7.23 -2.56 -3.50 -3.85 -4.19 -5.82 -4.94 28.75%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.